Martine Johanna Jager

35PUBLICATIONS
83CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer diagnosisMortalityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|May 16, 2026
Living tissues and dead objects in the eye: The first description of ocular immune privilege by J.C. van Dooremaal in Albrecht Von Graefe's Archiv für Ophthalmologie in 1873.

|Jul 24, 2025
Tumour progression shows decrease in PD-L1 expression in matched metastases/primary uveal melanomas.

Maria Chiara Gelmi, Gulçin Gezgin, Ellen Kapiteijn

|May 10, 2025
Deep learning-based system for automatic identification of benign and malignant eyelid tumours.

Wanlin Fan, Martine Johanna Jager, Weiwei Dai

|May 20, 2024
Chimeric Antigen Receptor T Cell with an Inducible Caspase-9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 Targeting.

Marco Ventin, Giulia Cattaneo, Shahrzad Arya

|Nov 25, 2023
Time Trends in the Treatment and Survival of 5036 Uveal Melanoma Patients in The Netherlands over a 30-Year Period.

Thaïs M L Tong, Esther Bastiaannet, Frank M Speetjens

|Jun 15, 2023
Patient-derived zebrafish xenografts of uveal melanoma reveal ferroptosis as a drug target.

Arwin Groenewoud, Jie Yin, Maria Chiara Gelmi

Pageof 6

Frequent Collaborators

7 joint publications

Robert M Verdijk

6 joint publications

Annemijn P A Wierenga

5 joint publications

Ulrich Pfeffer

4 joint publications

Zahra Souri